Tower Research Capital (TRC)’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.5K Sell
620
-152
-20% -$12.5K ﹤0.01% 2798
2025
Q4
$60.3K Buy
772
+390
+102% +$31.6K ﹤0.01% 2286
2025
Q3
$32.5K Sell
382
-1,364
-78% -$109K ﹤0.01% 2875
2025
Q2
$137K Buy
1,746
+1,380
+377% +$102K ﹤0.01% 2125
2025
Q1
$26.5K Sell
366
-4,018
-92% -$337K ﹤0.01% 2710
2024
Q4
$389K Buy
4,384
+1,630
+59% +$145K 0.01% 1236
2024
Q3
$233K Sell
2,754
-702
-20% -$62.3K 0.01% 1481
2024
Q2
$319K Buy
3,456
+2,325
+206% +$235K 0.01% 1718
2024
Q1
$128K Sell
1,131
-3,320
-75% -$331K ﹤0.01% 1697
2023
Q4
$415K Buy
4,451
+2,041
+85% +$180K 0.01% 1526
2023
Q3
$221K Buy
2,410
+2,243
+1,343% +$241K 0.01% 1366
2023
Q2
$20.3K Sell
167
-1,433
-90% -$155K ﹤0.01% 3373
2023
Q1
$157K Buy
1,600
+1,401
+704% +$134K 0.01% 1512
2022
Q4
$16K Sell
199
-1,417
-88% -$119K ﹤0.01% 3379
2022
Q3
$123K Buy
1,616
+805
+99% +$77.4K ﹤0.01% 2384
2022
Q2
$88K Buy
811
+653
+413% +$69.3K ﹤0.01% 2395
2022
Q1
$16K Sell
158
-152
-49% -$14.5K ﹤0.01% 3771
2021
Q4
$29K Sell
310
-1,524
-83% -$153K ﹤0.01% 3273
2021
Q3
$203K Buy
1,834
+1,048
+133% +$119K 0.01% 1811
2021
Q2
$91K Sell
786
-715
-48% -$82.2K ﹤0.01% 2511
2021
Q1
$156K Sell
1,501
-767
-34% -$95.4K ﹤0.01% 2216
2020
Q4
$273K Sell
2,268
-10,325
-82% -$1.04M 0.01% 1464
2020
Q3
$1.09M Buy
12,593
+10,278
+444% +$884K 0.01% 907
2020
Q2
$188K Buy
+2,315
New +$169K 0.01% 1841
2019
Q4
Sell
-502
Closed -$66K 4408
2019
Q3
$66K Sell
502
-238
-32% -$31K ﹤0.01% 1603
2019
Q2
$91K Buy
+740
New +$85K 0.01% 1224
2018
Q2
Sell
-1,321
Closed -$107K 4080
2018
Q1
$107K Buy
+1,321
New +$102K 0.01% 1210
2017
Q4
Sell
-1,981
Closed -$121K 4049
2017
Q3
$121K Buy
1,981
+1,381
+230% +$84.1K 0.01% 1178
2017
Q2
$36K Buy
+600
New +$38.3K ﹤0.01% 918
2017
Q1
Sell
-317
Closed -$22K 3950
2016
Q4
$22K Buy
+317
New +$20.2K ﹤0.01% 2054
2016
Q3
Sell
-100
Closed -$6K 4478
2016
Q2
$6K Sell
100
-545
-84% -$29.9K ﹤0.01% 3298
2016
Q1
$32K Buy
645
+595
+1,190% +$29.6K ﹤0.01% 1027
2015
Q4
$3K Buy
+50
New +$2.5K ﹤0.01% 3523
2015
Q3
Sell
-252
Closed -$14K 4802
2015
Q2
$14K Buy
252
+168
+200% +$8.32K ﹤0.01% 2416
2015
Q1
$4K Sell
84
-316
-79% -$13.4K ﹤0.01% 3435
2014
Q4
$17K Sell
400
-100
-20% -$3.94K ﹤0.01% 1723
2014
Q3
$18K Buy
+500
New +$17.7K ﹤0.01% 2396
2014
Q2
Sell
-1,714
Closed -$60K 4664
2014
Q1
$60K Buy
1,714
+1,564
+1,043% +$51.9K 0.01% 966
2013
Q4
$5K Sell
150
-2,726
-95% -$89.2K ﹤0.01% 3542
2013
Q3
$90K Buy
2,876
+2,167
+306% +$64K 0.01% 1391
2013
Q2
$20K Buy
+709
New +$18.7K ﹤0.01% 1727

Other funds holding USPH

Tower Research Capital (TRC)'s USPH Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its US Physical Therapy (USPH) stake by 20% in Q1 2026, selling an estimated $12.5K and leaving 620 shares worth $46.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2798.

Tower Research Capital (TRC) first reported a position in USPH in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.09M in Q3 2020. 229 funds tracked by Wall St. Rank hold USPH as of Q1 2026.

  • Tower Research Capital (TRC) held 620 shares of US Physical Therapy worth $46.5K as of Q1 2026.
  • Tower Research Capital (TRC) sold 152 US Physical Therapy shares in Q1 2026, an estimated $12.5K.
  • US Physical Therapy made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2798 holding.
  • Tower Research Capital (TRC) first reported a position in US Physical Therapy in Q2 2013 and has held it in 41 quarters since.
  • Tower Research Capital (TRC)'s US Physical Therapy position peaked at $1.09M in Q3 2020.
  • 229 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.